IGF1 and cancer: Since growth factor (e.g., IGF-I) and nutrient (e.g., amino acids) reductions extend lifespan and reduce cancer, and mTOR integrates responses, it was proposed that mTOR is central to the aging process and its chronic inhibition might delay or reduce the severity of cancer [93].